Project Grant R21OD040600
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $414,305 to the University of Wisconsin–Madison effective March 1, 2026, through February 28, 2031. This five-year Project Grant supports the development and implementation of advanced statistical genetics tools to address critical methodological challenges in drug target discovery and treatment optimization. The research program...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin - Madison a Project Grant totaling $580,507 under the Biomedical Research and Research Training program (CFDA 93.859) on May 6, 2026, with completion scheduled for February 28, 2031. This five-year research initiative investigates the mechanisms governing midbody remnants (MBRs)—large extracellular vesicles released during cell division—as novel mediators of...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $790,502 to the University of California, Santa Cruz through the Research Infrastructure Programs (CFDA 93.351) on June 15, 2026, to develop a genetic resource of C. elegans (nematode) strains expressing endogenously tagged secretome proteins. The project will create approximately 1,000 stable knock-in genetic stocks prioritizing high-value secretome genes, including 410 proteins with...
- Federal Grant Award Summary The National Institutes of Health Office of the Director awarded University of Wisconsin-Madison $1,038,908 through the Research Infrastructure Programs (CFDA 93.351) on July 1, 2026 to acquire a SCIEX ZenoTOF 7600+ time-of-flight mass spectrometry system. This high-resolution analytical instrumentation addresses critical analytical limitations in current mass spectrometry capabilities, including insufficient sensitivity, quantitative accuracy constraints, and low...
- Federal Grant Award Summary The National Institutes of Health Office of the Director awarded University of Wisconsin–Madison a $1.49 million Project Grant under the Trans-NIH Research Support program (CFDA 93.310) on September 16, 2025, with a completion date of August 31, 2027. This research initiative focuses on developing and characterizing humanized mouse models to study Down syndrome immune responses, specifically addressing the immune dysregulation associated with trisomy 21. The project...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Wisconsin–Madison a $418,331 Project Grant effective July 1, 2026, through May 31, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of advanced statistical methods for microbiome data analysis to address critical methodological challenges in large consortium-based microbiome studies. The project will deliver three...
- Federal Project Grant Summary The University of Colorado-Denver received a $779,657 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on July 15, 2025, with completion anticipated by June 30, 2029. This award supports the establishment and expansion of community-accessible resources for site-directed transgenesis in zebrafish, a critical research model for studying vertebrate development, regeneration, and...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $876,272 Project Grant from the National Science Foundation's Division of Integrative Organismal Systems under the Biological Sciences program (CFDA 47.074), awarded October 15, 2025, with completion targeted for September 30, 2028. This collaborative research initiative develops advanced CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) tools for bacterial functional genomics with application to marine...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $655,441 project grant award dated August 15, 2025, through the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351). The award funds the Cre-Driver Rat Resource Project (R24), which will develop, validate, and distribute transgenic rat models to the biomedical research community through August 31, 2029. The project leverages existing institutional...
- Federal Project Grant Award Summary Cornell University received a $432,204 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) beginning July 1, 2026 and concluding June 30, 2028. The award supports development of a novel tissue-specific protein labeling technique for use in Drosophila disease models. The primary deliverable is the establishment of a split-intein HaloTag (SIH) system that combines HaloTag...
The National Institutes of Health Office of the Director awarded University of Wisconsin–Madison a $418,641 Project Grant under the Research Infrastructure Programs (CFDA 93.351) for a two-year initiative running from July 1, 2026 through June 30, 2028. The project addresses critical validation challenges in Drosophila (fruit fly) research by developing and applying a novel genomic authentication pipeline to assess genetic integrity across widely-used laboratory fly stocks. The principal deliverables include: (1) characterization of 200 commonly-studied laboratory fly stocks to detect contamination and document genomic variation, and (2) detailed investigation of genetic and phenotypic variation within three key reference stocks by sequencing genomes and performing biomedical trait assays on 100 sub-lines sourced from different laboratories. These research outputs will provide the biomedical research community with evidence-based validation tools and characterization data to ensure reproducibility and comparability of experimental results across institutions. The project directly supports the NIH Office of Research Infrastructure Programs' mission to advance research resources and models for human disease studies. By illuminating discrepancies among nominally identical fly stocks maintained by different laboratories and developing practical authentication methods, this work strengthens the scientific rigor of Drosophila-based biomedical research—a critical model system for basic biology and disease modeling. The genomic authentication pipeline and resulting stock characterization data will serve as reusable research infrastructure with broad applicability across the research community.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $418.6k | 6/24/26 |